WebCINGAL 13-02, an open-label, follow-on study to Cingal 13-01. Anika Therapeutics, Inc.: study sponsor, Dr. Laszlo Hangody: global principal investigator, SynteractHCR: CRO. … Cingal is available in these countries worldwide. Anika is a global joint … CINGAL ® is a unique single-injection treatment proven to safely and … Anika is a global joint preservation company committed to delivering meaningful … CINGAL ® is a simple, physician-administered injection that delivers fast … WHAT IS IT? CINGAL ® is the first and only CE mark approved combination product … THE CINGAL DIFFERENCE. HA is vital for maintaining the function and elasticity of … The results from the CINGAL ® clinical study showed statistically significant … CINGAL demonstrated a very good safety profile in its clinical study as a … CINGAL is a transparent gel made from a natural substance called sodium … In a major clinical trial CINGAL 13-01, CINGAL ® demonstrated statistically … WebNov 1, 2024 · The Cingal 19-01 Phase III study is the third completed Phase III study of Cingal and, together with previous studies, has now demonstrated superiority over each of its active ingredients and ...
Toista Cingal®-injektio polven nivelrikkoon - ICHGCP
WebMar 6, 2015 · Cingal 13-01 was a multi-center, randomized, double-blind, Phase III study that enrolled 368 subjects at up to 20 sites in Canada and Europe. The Cingal 13-01 study objective was to assess the safety and effectiveness of a single injection of Cingal® for relief of joint pain and symptoms in patients with osteoarthritis (OA) of the knee. ... WebJun 1, 2016 · CINGAL is the first and only viscosupplement approved for use in the European Union that combines triamcinolone hexacetonide, a well-established, FDA … how do you spell deaconess
Anika Reveals Commercial Launch Of CINGAL In Europe - Anika
WebA single injection that provides the q uick pain relief of a corticosteroid with the long-term pain relief of a viscosupplement. Cingal® is the only viscosupplement that combines a corticosteroid for fast pain relief with a … WebCover Letter - Cingal 16-02 Statistical Analysis Plan for Protocol Version 4.0 A Randomized, Double-Blind, Active Comparator Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (Cingal®) to Provide Symptomatic Relief of Osteoarthritis of the Knee NCT # 03191903 phone spy installer